In vitro activity of U-76,252 (CS-807), a new oral cephalosporin
Open Access
- 1 July 1988
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 32 (7), 1082-1085
- https://doi.org/10.1128/aac.32.7.1082
Abstract
U-76,252 is the prodrug of U-76,253. MICs of U-76,253 were 0.015 to 0.06 microgram/ml for greater than or equal to 90% of the strains of Streptococcus spp., Haemophilus influenzae, and Proteus mirabilis; 0.25 to 1 microgram/ml for Branhamella catarrhalis, Escherichia coli, Klebsiella spp., and Citrobacter diversus; 1 to 8 micrograms/ml for Staphylococcus spp.; and 2 to greater than 16 micrograms/ml for other members of the family Enterobacteriaceae and Aeromonas hydrophila; for 72% of the latter group, MICs were less than or equal to 4 micrograms/ml. MICs for Pseudomonas aeruginosa and Enterococcus faecalis were greater than 16 micrograms/ml.This publication has 3 references indexed in Scilit:
- In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporinAntimicrobial Agents and Chemotherapy, 1987
- Modified microdilution susceptibility test for Staphylococci, Streptococci andHaemophilus spp.European Journal of Clinical Microbiology & Infectious Diseases, 1984
- Susceptibility of Enterobacter to Cefamandole: Evidence for a High Mutation Rate to ResistanceAntimicrobial Agents and Chemotherapy, 1976